Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study.
Pinchera B, Spirito L, Buonomo AR, Foggia M, Carrano R, Salemi F, Schettino E, Papa F, La Rocca R, Crocetto F, Napolitano L, Villari R, Gentile I. Pinchera B, et al. Among authors: villari r. Front Med (Lausanne). 2022 Jun 21;9:852973. doi: 10.3389/fmed.2022.852973. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35801204 Free PMC article.
Diabetes and COVID-19: The potential role of mTOR.
Pinchera B, Scotto R, Buonomo AR, Zappulo E, Stagnaro F, Gallicchio A, Viceconte G, Sardanelli A, Mercinelli S, Villari R, Foggia M, Gentile I; Federico II COVID Team. Pinchera B, et al. Among authors: villari r. Diabetes Res Clin Pract. 2022 Apr;186:109813. doi: 10.1016/j.diabres.2022.109813. Epub 2022 Mar 3. Diabetes Res Clin Pract. 2022. PMID: 35248653 Free PMC article. Review.
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis.
Zappulo E, Buonomo AR, Moccia M, Pinchera B, Villari R, Petracca M, Lanzillo R, Scotto R, Carotenuto A, Viceconte G, Schiano Moriello N, Bruno L, Gentile I, Brescia Morra V. Zappulo E, et al. Among authors: villari r. Mult Scler Relat Disord. 2022 Jul;63:103814. doi: 10.1016/j.msard.2022.103814. Epub 2022 Apr 21. Mult Scler Relat Disord. 2022. PMID: 35487032
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.
Scotto R, Buonomo AR, Iuliano A, Foggia M, Sardanelli A, Villari R, Pinchera B, Gentile I, Federico Ii Covid-Team. Scotto R, et al. Among authors: villari r. Vaccines (Basel). 2023 Jan 17;11(2):200. doi: 10.3390/vaccines11020200. Vaccines (Basel). 2023. PMID: 36851078 Free PMC article.
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience.
Pinchera B, Buonomo AR, Scotto R, Carrano R, Salemi F, Galluccio F, Guarino M, Viceconte G, Schiano Moriello N, Giaccone A, Gallicchio A, Zappulo E, Villari R, Gentile I; Federico II COVID team. Pinchera B, et al. Among authors: villari r. Transplantation. 2022 Jul 1;106(7):e343-e345. doi: 10.1097/TP.0000000000004150. Epub 2022 Mar 24. Transplantation. 2022. PMID: 35349534 Free PMC article. No abstract available.
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study.
Viceconte G, Ponsiglione A, Buonomo AR, Camera L, Scotto R, De Giorgi M, Pinto L, Pinchera B, Villari R, Foggia M, Gerundo G, Abete P, Brunetti A, Gentile I. Viceconte G, et al. Among authors: villari r. Infez Med. 2022 Dec 1;30(4):555-562. doi: 10.53854/liim-3004-10. eCollection 2022. Infez Med. 2022. PMID: 36482955 Free PMC article.
31 results